AF
TIL icon

Amalgamated Financial’s Instil Bio TIL Stock Holding History

Amalgamated Financial’s Portfolio TIL Stock Details TIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$81K Buy
+379
New +$88.6K ﹤0.01% 2234

Other funds holding TIL

CVV
Curative Ventures V Dallas, Texas $14.6M AUM 63.08% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
CI
CPMG Inc Dallas, Texas $37.1M AUM 74.35% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Amalgamated Financial's TIL Position: Q1 2022 in Review

Amalgamated Financial opened a new position in Instil Bio (TIL) in Q1 2022: 379 shares worth $81K. The stake represents ﹤0.01% of the portfolio and ranks #2234 among its holdings.

78 funds tracked by Wall St. Rank hold TIL as of Q1 2022.

  • Amalgamated Financial held 379 shares of Instil Bio worth $81K as of Q1 2022.
  • Instil Bio was a new Amalgamated Financial position in Q1 2022.
  • Instil Bio made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2234 holding.
  • 78 funds tracked by Wall St. Rank held Instil Bio as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.